Cargando…

Association between systemic immune-inflammation index (SII) and survival outcome in patients with primary glioblastoma

The purpose was to evaluate the prognostic value of systemic immune-inflammation index (SII) in glioblastoma patients. A total of 100 patients were retrospectively analyzed. We performed Kaplan–Meier and Cox regression analyses to determine the prognostic significance of SII. A nomogram was construc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chao, Li, Zhi-Qiang, Wang, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936030/ https://www.ncbi.nlm.nih.gov/pubmed/36800573 http://dx.doi.org/10.1097/MD.0000000000033050

Ejemplares similares

Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus
por: Feng, Ji-Feng, et al.
Publicado: (2017)

Prognostic Value of Systemic Immune-Inflammation Index (SII) in Patients with Glioblastoma: A Comprehensive Study Based on Meta-Analysis and Retrospective Single-Center Analysis
por: Yang, Chao, et al.
Publicado: (2022)

Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma
por: Gao, Yibo, et al.
Publicado: (2019)

Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection
por: Jomrich, Gerd, et al.
Publicado: (2019)

The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
por: Bartl, Thomas, et al.
Publicado: (2020)

High systemic immune-inflammation index predicts poor prognosis in advanced lung adenocarcinoma patients treated with EGFR-TKIs
por: Deng, Chao, et al.
Publicado: (2019)

Exercise reduces systemic immune inflammation index (SII) in childhood cancer patients
por: Winker, Matteo, et al.
Publicado: (2021)

Systemic immune-inflammation index predicts prognosis in patients with different EGFR-mutant lung adenocarcinoma
por: Ju, Qing, et al.
Publicado: (2021)

Systemic immune‐inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non‐small cell lung cancer
por: Guo, Wei, et al.
Publicado: (2019)

Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors
por: Li, Chan, et al.
Publicado: (2018)

Systemic Immune-Inflammation Index (SII) Predicts Increased Severity in Psoriasis and Psoriatic Arthritis
por: YORULMAZ, AHU, et al.
Publicado: (2020)

Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia
por: Tosu, Aydın Rodi, et al.
Publicado: (2021)

Systemic Immune-Inflammation Index (SII) Correlates with Disease Severity in Hidradenitis Suppurativa Patients
por: Hayran, Yıldız, et al.
Publicado: (2023)

Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer
por: Chen, Chang, et al.
Publicado: (2020)

Characteristics and management of tumor treating fields-related dermatological complications in patients with glioblastoma
por: Yang, Chao, et al.
Publicado: (2023)

Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer
por: Huang, Yihong, et al.
Publicado: (2021)

Exploring the Correlation Between the Systemic Immune Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and Type 2 Diabetic Retinopathy
por: Wang, Shuqi, et al.
Publicado: (2023)

Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value in metastatic castration-resistant prostate cancer patients who underwent (177)Lu–PSMA-617
por: Şahin, Elif, et al.
Publicado: (2023)

Prognostic value of the systemic inflammation response index in human malignancy: A meta-analysis
por: Wei, Lishuang, et al.
Publicado: (2020)

Association of the systemic immune-inflammation index (SII) and clinical outcomes in patients with stroke: A systematic review and meta-analysis
por: Huang, Yong-Wei, et al.
Publicado: (2022)

Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide
por: Quan, Rencui, et al.
Publicado: (2020)

Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
por: Du, Zhongxiang, et al.
Publicado: (2023)

Extent of resection and survival in patients with glioblastoma multiforme: Systematic review and meta-analysis
por: Revilla-Pacheco, Francisco, et al.
Publicado: (2021)

Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study
por: Lei, Yanna, et al.
Publicado: (2022)

The role of systemic immune-inflammation index (SII) in the differential diagnosis of granulomatous and reactive LAP diagnosed by endobronchial ultrasonography
por: Kerget, Buğra, et al.
Publicado: (2023)

Predictive value of systemic immune inflammation index (SII) and prognostic nutritional index (PNI) on mortality after below-knee amputation
por: Yilmaz, Selçuk, et al.
Publicado: (2023)

Comparison of the geriatric nutritional risk index and the prognostic nutritional index in determining survival outcome in patients with non-small cell lung cancer undergoing surgical resection: A cohort study
por: An, Soomin, et al.
Publicado: (2022)

A new immune checkpoint-associated nine-gene signature for prognostic prediction of glioblastoma
por: Jin, Xiao, et al.
Publicado: (2023)

Clinical and survival outcomes of colectomy for transverse colon cancer in elderly patients
por: Liu, Xiang-Jun, et al.
Publicado: (2023)

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas
por: Chen, Jun-Rui, et al.
Publicado: (2016)

Evaluation of Body Mass Index and Survival of Nasopharyngeal Carcinoma by Propensity-Matched Analysis: An Observational Case-Control Study
por: OuYang, Pu-Yun, et al.
Publicado: (2016)

Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: A meta-analysis
por: Wang, Bolin, et al.
Publicado: (2020)

Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis
por: Zhou, Yuting, et al.
Publicado: (2022)

Systemic Immune-Inflammation Index (SII) Can Be an Early Indicator for Predicting the Severity of Acute Pancreatitis: A Retrospective Study
por: Liu, Xingming, et al.
Publicado: (2021)

Systemic immune-inflammation index (SII): A More Promising Inflammation-Based Prognostic Marker for Patients with synchronic colorectal peritoneal carcinomatosis
por: Yan, Qian, et al.
Publicado: (2020)

A retrospective study about association of dynamic systemic immune-inflammation index (SII) with 180-day functional outcome after basal ganglia intracerebral hemorrhage
por: Liang, Zhang, et al.
Publicado: (2023)

Value of the Systemic Immune-Inflammatory Index (SII) in Predicting the Prognosis of Patients With Peripartum Cardiomyopathy
por: Zhang, Yuan, et al.
Publicado: (2022)

Preoperative Systemic Immune–Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I–II Gastric Cancer After Radical Surgery
por: He, Kang, et al.
Publicado: (2022)

The association between the composite quality measure “textbook outcome” and long term survival in operated colon cancer
por: Yang, Ching-Chieh, et al.
Publicado: (2020)

Association of systemic immune-inflammation index (SII) and aggregate index of systemic inflammation (AISI) with thyroid nodules in patients with type 2 diabetes mellitus: a retrospective study
por: Cao, Can, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jt313s31e6vrrdsqhb9lf986v2